Research Advisory Panel content
What is the Research Advisory Panel?
The RAP is a group of people who assess applications for funding and help Yorkshire Cancer Research make funding decisions. The RAP includes:
- Expert members – clinicians and scientists with backgrounds and expertise relating to cancer research
- Stakeholder members – people with lived experience of cancer, including people who have or have had cancer, carers, friends and family, and other interested members of the public
Why do we need stakeholder members?
Researchers, clinicians and funders may not have first-hand experience of the condition or disease they want to research.
People affected by cancer are at the heart of the charity's work and we want to incorporate their unique and valuable perspectives of living with cancer into our decision-making. Stakeholder members are from across Yorkshire and represent the people of Yorkshire.
Insights from patients and the public help to make research more relevant to the needs of patients, service users, carers and loved ones, leading to healthcare solutions that better meet their needs.
Involving stakeholders in charity funding decisions helps us ensure that we not only fund the best research projects, but those that represent the views of people living with cancer in Yorkshire.
Interested in joining?
If you live in Yorkshire and are interested in joining the panel, find out more about who the stakeholders are and what they do.
Quote from Darren Pattie
I joined the Research Advisory Panel at Yorkshire Cancer Research because I want to use my experience to help others. The voice of those affected by cancer is so important when it comes to research, helping to provide a more balanced view rather than purely focusing on the clinical trials and scientific research.
On a personal level, being a member of the panel has helped me to re-engage with the world, something I’ve not been able to do as much while recovering from my donor stem cell and bone marrow transplant."
Quote from Prof Ananya Choudhury
"As a member of the Research Advisory Panel for Yorkshire Cancer Research for four years, it was a privilege to be involved in shaping research strategy, enabling better outcomes for people with cancer and bringing innovation to cancer care."